Clinical Trial Update: Gabapentin in Fibromyalgia Trial (GIFT) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating gabapentin for fibromyalgia, the GIFT study, completed Phase 2 and Phase 3 trials sponsored by NIAMS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Fibromyalgia | Phase 2, Phase 3 | Status: COMPLETED